<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: bone marrow cells</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Umbilical cord cells outperform bone marrow cells in repairing damaged hearts</title>
   	 <description>A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, &quot;Human Umbilical Cord PeriVascular Cells&quot; (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.</description>
     <link>http://medicalxpress.com/news/2012-11-umbilical-cord-cells-outperform-bone.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 15 Nov 2012 12:29:11 EST</pubDate>
	 <guid isPermaLink="false">news272204941</guid>
	 
</item>
<item>
     <title>Cryopreservation of induced pluripotent stem cells improved the most by one product</title>
   	 <description>In a study to determine the best cryopreservation (freezing) solution to maintain induced pluripotent stem (iPS) cells, a team of researchers from Japan compared 12 kinds of commercially prepared and readily available cryopreservation solutions and found that &quot;Cell Banker 3&quot; out-performed the other 11 solutions by allowing iPS cells to be preserved for a year at −80°C degrees C in an undifferentiated state.</description>
     <link>http://medicalxpress.com/news/2012-09-cryopreservation-pluripotent-stem-cells-product.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 25 Sep 2012 17:02:05 EST</pubDate>
	 <guid isPermaLink="false">news267811301</guid>
	 
</item>
<item>
     <title>Team creates a unique mouse model for the study of aplastic anaemia</title>
   	 <description>Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).</description>
     <link>http://medicalxpress.com/news/2012-08-team-unique-mouse-aplastic-anaemia.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 29 Aug 2012 10:55:55 EST</pubDate>
	 <guid isPermaLink="false">news265456549</guid>
	 
</item>
<item>
     <title>Southampton scientists to investigate ways to prevent life-threatening complications in transplant patients</title>
   	 <description>Scientists from the University of Southampton have received a grant from the blood cancer charity Leukaemia &amp; Lymphoma Research to explore ways of preventing life-threatening side effects in patients receiving bone marrow transplants.</description>
     <link>http://medicalxpress.com/news/2012-08-southampton-scientists-ways-life-threatening-complications.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 21 Aug 2012 09:21:45 EST</pubDate>
	 <guid isPermaLink="false">news264759692</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/southamptons.jpg" width="90" height="90" />
</item>
<item>
     <title>B cell survival holds key to chronic graft vs. host disease</title>
   	 <description>Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their long-term survival.</description>
     <link>http://medicalxpress.com/news/2012-08-cell-survival-key-chronic-graft.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 16 Aug 2012 10:04:25 EST</pubDate>
	 <guid isPermaLink="false">news264330235</guid>
	 
</item>
<item>
     <title>Clinical trial seeks to cure advanced Crohn's disease using bone marrow transplant</title>
   	 <description>Researchers at Fred Hutchinson Cancer Research Center have opened a clinical trial to test the theory that giving a patient a new immune system can cure severe cases of Crohn's disease, a chronic inflammatory condition of the gastrointestinal tract.</description>
     <link>http://medicalxpress.com/news/2012-07-clinical-trial-advanced-crohn-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 23 Jul 2012 12:41:46 EST</pubDate>
	 <guid isPermaLink="false">news262266094</guid>
	 
</item>
<item>
     <title>A new target in acute myeloid leukemia</title>
   	 <description>Acute myeloid leukemia, a common leukemia in adults, is characterized by aberrant proliferation of cancerous bone marrow cells. Activating mutations in a protein receptor known as FLT3 receptor are among the most prevalent mutations observed in acute myeloid leukemias. FLT3 mutants are thought to activate several signaling pathways that contribute to cancer development. </description>
     <link>http://medicalxpress.com/news/2012-07-acute-myeloid-leukemia.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 16 Jul 2012 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news261655555</guid>
	 
</item>
<item>
     <title>Study results: Adult stem cells from bone marrow</title>
   	 <description>Researchers from the University of Maryland School of Maryland report promising results from using adult stem cells from bone marrow in mice to help create tissue cells of other organs, such as the heart, brain and pancreas - a scientific step they hope may lead to potential new ways to replace cells lost in diseases such as diabetes, Parkinson's or Alzheimer's. The research in collaboration with the University of Paris Descartes is published online in the July 2, 2012 edition of Comptes Rendus Biologies, a publication of the French Academy of Sciences.</description>
     <link>http://medicalxpress.com/news/2012-07-results-adult-stem-cells-bone.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 03 Jul 2012 11:15:55 EST</pubDate>
	 <guid isPermaLink="false">news260532947</guid>
	 
</item>
<item>
     <title>Gene therapy can correct forms of severe combined immunodeficiency</title>
   	 <description>Severe combined immunodeficiency is defect in the immune system that results in a loss of the adaptive immune cells known as B cells and T cells. Mutations in several different genes can lead to the development of severe combined immunodeficiency, including mutation of the adenosine deaminase (ADA) gene.</description>
     <link>http://medicalxpress.com/news/2012-05-gene-therapy-severe-combined-immunodeficiency.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 24 May 2012 12:00:56 EST</pubDate>
	 <guid isPermaLink="false">news257078057</guid>
	 
</item>
<item>
     <title>SCAI: Ixmyelocel-T studied for dilated cardiomyopathy</title>
   	 <description>(HealthDay) -- For patients with dilated cardiomyopathy, treatment with an autologous bone marrow-derived, expanded multi-cell product, ixmyelocel-T, is well tolerated and associated with improved symptoms at one year, according to a study presented at the Society for Cardiovascular Angiography and Interventions 2012 Scientific Sessions, held from May 9 to 12 in Las Vegas.</description>
     <link>http://medicalxpress.com/news/2012-05-scai-ixmyelocel-t-dilated-cardiomyopathy.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 15 May 2012 05:50:01 EST</pubDate>
	 <guid isPermaLink="false">news256276097</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/scaiixmyeloc.jpg" width="90" height="90" />
</item>
<item>
     <title>'Fertilizing' bone marrow helps answer why some cancers spread to bones</title>
   	 <description>Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.</description>
     <link>http://medicalxpress.com/news/2012-05-fertilizing-bone-marrow-cancers-bones.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 15 May 2012 00:20:07 EST</pubDate>
	 <guid isPermaLink="false">news256233774</guid>
	 
</item>
<item>
     <title>Stem cell therapy possibly helpful in heart failure patients</title>
   	 <description>A new study found that using a patient's own bone marrow cells may help repair damaged areas of the heart caused by heart failure, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the field.</description>
     <link>http://medicalxpress.com/news/2012-03-stem-cell-therapy-possibly-heart.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 26 Mar 2012 09:13:33 EST</pubDate>
	 <guid isPermaLink="false">news251971999</guid>
	 
</item>
<item>
     <title>Bone marrow stem cells improve heart function, study finds</title>
   	 <description>A research network led by a Mayo Clinic physician found that stem cells derived from heart failure patients' own bone marrow and injected into their hearts improved the function of the left ventricle, the heart's pumping chamber. Researchers also found that certain types of the stem cells were associated with the largest improvement and warrant further study.</description>
     <link>http://medicalxpress.com/news/2012-03-bone-marrow-stem-cells-heart.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 26 Mar 2012 09:12:36 EST</pubDate>
	 <guid isPermaLink="false">news251971945</guid>
	 
</item>
<item>
     <title>Study examines treatment of heart failure with bone marrow cells</title>
   	 <description>Use of a patient's bone marrow cells for treating chronic ischemic heart failure did not result in improvement on most measures of heart function, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the American College of Cardiology's annual scientific sessions.</description>
     <link>http://medicalxpress.com/news/2012-03-treatment-heart-failure-bone-marrow.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sat, 24 Mar 2012 19:10:58 EST</pubDate>
	 <guid isPermaLink="false">news251835048</guid>
	 
</item>
<item>
     <title>Cell therapy using patient's own bone marrow may present option for heart disease</title>
   	 <description>Cell therapy may present an option for patients with ischemic heart disease to use their own bone marrow cells to repair the damaged areas of their hearts, and may pave the way for future treatment options, according to the FOCUS trial, which will be presented as a late-breaking clinical trial March 24 at the 61st annual American College of Cardiology (ACC) scientific session.</description>
     <link>http://medicalxpress.com/news/2012-03-cell-therapy-patient-bone-marrow.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sat, 24 Mar 2012 19:04:17 EST</pubDate>
	 <guid isPermaLink="false">news251834642</guid>
	 
</item>
<item>
     <title>Live from the thymus: T-cells on the move</title>
   	 <description>T-cells are the immune system's security force. They seek out pathogens and rogue cells in the body and put them out of action. Their precursors are formed in the bone marrow and migrate from there into the thymus. Here, they mature and differentiate to perform a variety of tasks. Scientists at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg have now succeeded for the first time in observing the maturation of immune cells in live zebrafish embryos. During their development, the immune cells migrate into and out of the thymus more than once. The zebrafish is thus an ideal animal model for studying the dynamic processes of immune cell development.</description>
     <link>http://medicalxpress.com/news/2012-02-thymus-t-cells.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 17 Feb 2012 12:41:46 EST</pubDate>
	 <guid isPermaLink="false">news248704887</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/livefromthet.jpg" width="90" height="91" />
</item>
<item>
     <title>New procedure bests standard of care for fixing damaged cartilage</title>
   	 <description>A new study has demonstrated that a procedure wherein healthy cartilage is transplanted to fix an area of damaged cartilage (osteoarticular cartilage transplantation or OATS procedure) is superior to the standard of care for repairing cartilage defects. It is thought that fixing such lesions may ultimately help to prevent the onset of osteoarthritis, and get athletic individuals back to sporting activities reliably. The study by Hospital for Special Surgery researchers was reported at the annual meeting of the American Academy of Orthopaedic Surgeons, Feb. 7-11.</description>
     <link>http://medicalxpress.com/news/2012-02-procedure-bests-standard-cartilage.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Wed, 08 Feb 2012 04:00:01 EST</pubDate>
	 <guid isPermaLink="false">news247895057</guid>
	 
</item>
<item>
     <title>Bone marrow-derived cells differentiate in the brain through mechanisms of plasticity</title>
   	 <description>Bone marrow-derived stem cells (BMDCs) have been recognized as a source for transplantation because they can contribute to different cell populations in a variety of organs under both normal and pathological conditions. Many BMDC studies have been aimed at repairing damaged brain tissue or helping to restore lost neural function, with much research focused on BMDC transplants to the cerebellum at the back of the brain. In a recent study, a research team from Spain has found that BMDCs, can contribute to a variety of neural cell types in other areas of the brain as well, including the olfactory bulb, because of a mechanism of &quot;plasticity&quot;.</description>
     <link>http://medicalxpress.com/news/2011-12-bone-marrow-derived-cells-differentiate-brain.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 19 Dec 2011 16:06:43 EST</pubDate>
	 <guid isPermaLink="false">news243533185</guid>
	 
</item>
<item>
     <title>Microscopic cells race to victory in first World Cell Race at ASCB meeting</title>
   	 <description>A &quot;team&quot; of fast-moving, bone marrow stem cells from a research laboratory in Singapore has run away with the first World Cell Race, finishing first with a cellular speed record of 5.2 microns per minute (or 0.000204 inches per minute) in results announced today at the 51st Annual Meeting of the American Society for Cell Biology (ASCB).</description>
     <link>http://medicalxpress.com/news/2011-12-microscopic-cells-victory-world-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 03 Dec 2011 02:52:29 EST</pubDate>
	 <guid isPermaLink="false">news242102995</guid>
	 
</item>
<item>
     <title>Organ engineering: Possibilities and challenges ahead</title>
   	 <description>Cartilage, bone, and skin can already be regenerated in vitro, and these tissues are currently available for clinical applications. However, regeneration of more complex tissues such as the liver and pancreas has yet to be fully realized.</description>
     <link>http://medicalxpress.com/news/2011-10-possibilities.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 31 Oct 2011 11:56:30 EST</pubDate>
	 <guid isPermaLink="false">news239280984</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/1268.jpg" width="90" height="90" />
</item>
<item>
     <title>Bone marrow cells migrate to tumors and can slow their growth</title>
   	 <description>Bone marrow-derived cells (BMDCs) participate in the growth and spread of tumors of the breast, brain, lung, and stomach. To examine the role of BMDCs, researchers developed a mouse model that could be used to track the migration of these cells while tumors formed and expanded. Their results, published in the November issue of The American Journal of Pathology, strongly suggest that more effective cancer treatments may be developed by exploiting the mechanism by which bone marrow cells migrate to tumors and retard their proliferation.</description>
     <link>http://medicalxpress.com/news/2011-10-bone-marrow-cells-migrate-tumors.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 07 Oct 2011 09:38:51 EST</pubDate>
	 <guid isPermaLink="false">news237199123</guid>
	 
</item>
<item>
     <title>Study identifies weakness in heart attack therapy</title>
   	 <description>A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.</description>
     <link>http://medicalxpress.com/news/2011-09-weakness-heart-therapy.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 20 Sep 2011 12:04:44 EST</pubDate>
	 <guid isPermaLink="false">news235739068</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/studyidentif.jpg" width="90" height="90" />
</item>
<item>
     <title>Vaccine linked to 'bleeding calf syndrome'</title>
   	 <description>Bleeding calf syndrome (bovine neonatal pancytopenia or BNP) affects new born calves resulting in low blood cell counts and depletion of the bone marrow. It first emerged in 2007 and a serious number of cases are reported each year. In affected calves, bone marrow cells which produce platelets are also destroyed. Consequently the calves' blood does not clot and they appear to bleed through undamaged skin. There is evidence that BNP is linked to the use of a particular vaccine against &quot;Bovine viral diarrhea virus&quot; (BVDV).</description>
     <link>http://medicalxpress.com/news/2011-08-vaccine-linked-calf-syndrome.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 30 Aug 2011 03:33:06 EST</pubDate>
	 <guid isPermaLink="false">news233893965</guid>
	 
</item>
<item>
     <title>Hair-cell-derived patient-specific heart cells for disease modeling and drug screening</title>
   	 <description>Hair follicle keratinocytes offer a simple and accessible route to generate patient-specific induced pluripotent stem cells, iPSCs, with minimum inconvenience for the patients, shows study presented at the ESC Congress 2011 today.</description>
     <link>http://medicalxpress.com/news/2011-08-hair-cell-derived-patient-specific-heart-cells-disease.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 29 Aug 2011 10:14:30 EST</pubDate>
	 <guid isPermaLink="false">news233831654</guid>
	 
</item>
<item>
     <title>Bone marrow transplantation may increase cancer resistance in patients</title>
   	 <description>Bone marrow transplantation with genetically modified cells may prolong the period of cancer-free survival, suggests a study led by Dr. Vivek Rangnekar, associate director of translational research for the Markey Cancer Center at the University of Kentucky.</description>
     <link>http://medicalxpress.com/news/2011-08-bone-marrow-transplantation-cancer-resistance.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 24 Aug 2011 16:05:13 EST</pubDate>
	 <guid isPermaLink="false">news233420565</guid>
	 
</item>
<item>
     <title>Penn researchers describe key molecule that keeps immune cell development on track</title>
   	 <description>In the latest issue of Nature, researchers at the Perelman School of Medicine at the University of Pennsylvania clarify the role of two proteins key to T-cell development. They found that one well-known protein called Notch passes off much of its role during T-cell maturation to another protein called TCF-1. T cells are required for many aspects of immunity, and understanding how these proteins influence the production of infection-fighting cells could improve treatments for immune-suppressed patients.</description>
     <link>http://medicalxpress.com/news/2011-08-penn-key-molecule-immune-cell.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 08 Aug 2011 13:30:06 EST</pubDate>
	 <guid isPermaLink="false">news232025982</guid>
	 
</item>
<item>
     <title>Single drug and soft environment can increase platelet production: research</title>
   	 <description>Humans produce billions of clot-forming platelets every day, but there are times when there aren't enough of them, such as with certain diseases or during invasive surgery. Now, University of Pennsylvania researchers have demonstrated that a single drug can induce bone marrow cells called megakaryocytes to quadruple the number of platelets they produce.</description>
     <link>http://medicalxpress.com/news/2011-07-drug-soft-environment-platelet-production_1.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 13 Jul 2011 10:27:43 EST</pubDate>
	 <guid isPermaLink="false">news229771607</guid>
	 
</item>
<item>
     <title>New study identifies new potential approaches to treat myelofibrosis</title>
   	 <description>(Medical Xpress) -- A new study conducted by a team of researchers at Boston University School of Medicine (BUSM) sheds light on a possible new approach to treat the bone marrow disease known as myelofibrosis by inhibiting an enzyme that connects extracellular fibers. The study, published online in the Journal of Biological Chemistry, was conducted under the direction of Katya Ravid, PhD, professor of medicine and biochemistry and director of the Evans Center for Interdisciplinary Biomedical Research at BUSM.</description>
     <link>http://medicalxpress.com/news/2011-06-potential-approaches-myelofibrosis.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 23 Jun 2011 14:50:48 EST</pubDate>
	 <guid isPermaLink="false">news228059438</guid>
	 
</item>
<item>
     <title>Gene-modified stem cells help protect bone marrow from toxic side effects of chemotherapy</title>
   	 <description>Although chemotherapy is used to kill cancer cells, it can also have a strong toxic effect on normal cells such as bone marrow and blood cells, often limiting the ability to use and manage the chemotherapy treatment. Researchers at Fred Hutchinson Cancer Research Center reported at today's annual meeting of the American Society of Gene and Cell Therapy in Seattle that one possible approach to reduce this toxic effect on bone marrow cells is to modify the cells with a gene that makes them resistant to chemotherapy.</description>
     <link>http://medicalxpress.com/news/2011-05-gene-modified-stem-cells-bone-marrow.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 21 May 2011 05:36:52 EST</pubDate>
	 <guid isPermaLink="false">news225174980</guid>
	 
</item>
<item>
     <title>Scientists discover new method for engineering human tissue regeneration</title>
   	 <description>If pending clinical trials prove successful, a new discovery published in The FASEB Journal could represent a major scientific leap toward human tissue regeneration and engineering. In a research report appearing online, Yale scientists provide evidence to support a major paradigm shift in this specialty area from the idea that cells added to a graft before implantation are the building blocks of tissue, to a new belief that engineered tissue constructs can actually induce or augment the body's own reparative mechanisms, including complex tissue regeneration.</description>
     <link>http://medicalxpress.com/news/2011-05-scientists-method-human-tissue-regeneration.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 12 May 2011 16:32:51 EST</pubDate>
	 <guid isPermaLink="false">news224436750</guid>
	 
</item>


</channel>
</rss>
